Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded
February 4, 2025
Broomfield, CO, February 4, 2025 – PRISM MediaWire – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and